Life Science Investing Adicet Bio Reports Third Quarter 2025 Financial Results and Provides Business Updates 05 November
Life Science Investing Adicet Bio to Participate in a Fireside Chat at the Guggenheim 2nd Annual Healthcare Innovation Conference 28 October
Life Science Investing Adicet Bio Announces First Patient Dosed in Phase 1 Clinical Trial of ADI-001 in Treatment-Refractory Rheumatoid Arthritis 16 October
